A Search Service for Abbreviation / Long Form
■ Abbreviation / Long Form : EnAd / enadenotucirev
[Related PubMed/MEDLINE]
Total Number of Papers:
10
[Entries Per Page]
5
10
20
50
100
per page
Page Control
Page:
of
Abbreviation:
EnAd
(
>> Co-occurring Abbreviation
)
Long Form:
enadenotucirev
Abbreviation Variation
EnAd (10 times)
Long Form Variation
enadenotucirev (5 times)
Enadenotucirev (4 times)
EnAdenotucirev (1 time)
Pair(Abbreviation/Long Form) Variation
EnAd / enadenotucirev (5 times)
EnAd / Enadenotucirev (4 times)
EnAd / EnAdenotucirev (1 time)
No.
Year
Title
Co-occurring Abbreviation
1
2020
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR).
CEDAR
,
TiTE-CRM
2
2020
Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion.
HIF
3
2019
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.
FRbeta
,
TAMs
4
2019
Polyvalent Diazonium Polymers Provide Efficient Protection of Oncolytic Adenovirus Enadenotucirev from Neutralizing Antibodies while Maintaining Biological Activity In Vitro and In Vivo.
polyHPMA
5
2018
Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells.
---
6
2018
Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirusin murine cancer cells.
---
7
2017
Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer.
Ad5
8
2017
Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies.
BiTE
9
2017
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.
---
10
2015
Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.
aDNAse I
,
C-ABC
,
PK